Effects of Sorafenib and Quercetin Alone or in Combination in Treating Hepatocellular Carcinoma: In Vitro and In Vivo Approaches

Sorafenib is the first drug approved to treat advanced hepatocellular carcinoma (HCC) and continues as the gold-standard therapy against HCC. However, acquired drug resistance represents a main concern about sorafenib therapy. The flavanol quercetin found in plants has shown great anti-cancer and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdu, Suzan, Juaid, Nouf, Amin, Amr, Moulay, Mohamed, Miled, Nabil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697794/
https://www.ncbi.nlm.nih.gov/pubmed/36432184
http://dx.doi.org/10.3390/molecules27228082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697794/
https://www.ncbi.nlm.nih.gov/pubmed/36432184
http://dx.doi.org/10.3390/molecules27228082

Ejemplares similares